SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Molina Healthcare, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97’

On:  Tuesday, 2/13/24, at 5:16pm ET   ·   For:  12/31/23   ·   Accession #:  1179929-24-33   ·   File #:  1-31719

Previous ‘10-K’:  ‘10-K’ on 2/13/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   17 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/13/24  Molina Healthcare, Inc.           10-K       12/31/23  122:32M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.09M 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     32K 
 3: EX-3.3      Articles of Incorporation/Organization or Bylaws    HTML     31K 
 4: EX-10.3     Material Contract                                   HTML     64K 
 5: EX-10.4     Material Contract                                   HTML    161K 
 6: EX-21.1     Subsidiaries List                                   HTML     40K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     31K 
12: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     44K 
                Awarded Compensation                                             
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     33K 
18: R1          Cover Page                                          HTML     99K 
19: R2          Audit Information                                   HTML     37K 
20: R3          Consolidated Statements of Income                   HTML    123K 
21: R4          Consolidated Statements of Comprehensive Income     HTML     58K 
22: R5          Consolidated Balance Sheets                         HTML    127K 
23: R6          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
24: R7          Consolidated Statements of Stockholders? Equity     HTML     79K 
25: R8          Consolidated Statements of Cash Flows               HTML    123K 
26: R9          Organization and Basis of Presentation              HTML     39K 
27: R10         Significant Accounting Policies                     HTML     91K 
28: R11         Net Income Per Share                                HTML     56K 
29: R12         Business Combinations                               HTML     48K 
30: R13         Fair Value Measurements                             HTML     93K 
31: R14         Investments                                         HTML    138K 
32: R15         Property, Equipment, and Capitalized Software, Net  HTML     60K 
33: R16         Leases                                              HTML    137K 
34: R17         Goodwill and Intangible Assets, Net                 HTML     69K 
35: R18         Medical Claims and Benefits Payable                 HTML    150K 
36: R19         Debt                                                HTML     66K 
37: R20         Income Taxes                                        HTML     94K 
38: R21         Stockholders' Equity                                HTML     89K 
39: R22         Employee Benefit Plans                              HTML     35K 
40: R23         Commitments and Contingencies                       HTML     46K 
41: R24         Segments                                            HTML     70K 
42: R25         Condensed Financial Information of Registrant       HTML    147K 
43: R26         Pay vs Performance Disclosure                       HTML     44K 
44: R27         Insider Trading Arrangements                        HTML     38K 
45: R28         Significant Accounting Policies (Policies)          HTML    120K 
46: R29         Significant Accounting Policies (Tables)            HTML     61K 
47: R30         Net Income Per Share (Tables)                       HTML     56K 
48: R31         Business Combinations (Tables)                      HTML     47K 
49: R32         Fair Value Measurements (Tables)                    HTML     91K 
50: R33         Investments (Tables)                                HTML    138K 
51: R34         Property, Equipment, and Capitalized Software, Net  HTML     58K 
                (Tables)                                                         
52: R35         Leases (Tables)                                     HTML    100K 
53: R36         Goodwill and Intangible Assets, Net (Tables)        HTML     73K 
54: R37         Medical Claims and Benefits Payable (Tables)        HTML    154K 
55: R38         Debt (Tables)                                       HTML     66K 
56: R39         Income Taxes (Tables)                               HTML     96K 
57: R40         Stockholders' Equity (Tables)                       HTML     84K 
58: R41         Segments (Tables)                                   HTML     65K 
59: R42         Condensed Financial Information of Registrant       HTML    148K 
                (Tables)                                                         
60: R43         Organization and Basis of Presentation (Details)    HTML     48K 
61: R44         Significant Accounting Policies - Cash, Cash        HTML     41K 
                Equivalents, and Restricted Cash (Details)                       
62: R45         Significant Accounting Policies - Additional        HTML     80K 
                Information (Details)                                            
63: R46         Significant Accounting Policies - Receivables       HTML     40K 
                (Details)                                                        
64: R47         Net Income Per Share (Details)                      HTML     78K 
65: R48         Business Combinations - Narrative (Details)         HTML     56K 
66: R49         Business Combinations - Schedule of The             HTML     56K 
                Provisional Fair Values Assigned To Assets                       
                Acquired and Liabilities Assumed (Details)                       
67: R50         Business Combinations - Intangible Assets           HTML     44K 
                (Details)                                                        
68: R51         Fair Value Measurements - Financial Instruments on  HTML     81K 
                a Recurring Basis (Details)                                      
69: R52         Fair Value Measurements - Additional Information    HTML     38K 
                (Details)                                                        
70: R53         Fair Value Measurements - Long-Term Debt (Details)  HTML     54K 
71: R54         Investments - Schedule of Investments (Details)     HTML     63K 
72: R55         Investments - Contractual Maturities (Details)      HTML     59K 
73: R56         Investments - Narrative (Details)                   HTML     50K 
74: R57         Investments - Available-for-Sale (Details)          HTML     78K 
75: R58         Investments - Balances of Restricted Investments    HTML     45K 
                (Details)                                                        
76: R59         Property, Equipment, and Capitalized Software, Net  HTML     50K 
                - Additional Information (Details)                               
77: R60         Property, Equipment, and Capitalized Software, Net  HTML     55K 
                - Summary of Property, Equipment, and Capitalized                
                Software (Details)                                               
78: R61         Property, Equipment, and Capitalized Software, Net  HTML     43K 
                - Depreciation and Amortization (Details)                        
79: R62         Leases - Narrative (Details)                        HTML     51K 
80: R63         Leases - Components of Lease Expense (Details)      HTML     42K 
81: R64         Leases - Supplemental Cash Flow (Details)           HTML     47K 
82: R65         Leases - Supplemental Balance Sheet Information     HTML     62K 
                (Details)                                                        
83: R66         Leases - Lease Maturities (Details)                 HTML     72K 
84: R67         Goodwill and Intangible Assets, Net - Balances of   HTML     46K 
                Goodwill (Details)                                               
85: R68         Goodwill and Intangible Assets, Net - Intangible    HTML     47K 
                Assets Balances (Details)                                        
86: R69         Goodwill and Intangible Assets, Net - Additional    HTML     43K 
                Information (Details)                                            
87: R70         Medical Claims and Benefits Payable - Medical       HTML     41K 
                Claims and Future Benefits (Details)                             
88: R71         Medical Claims and Benefits Payable - Additional    HTML     35K 
                Information (Details)                                            
89: R72         Medical Claims and Benefits Payable - Components    HTML     76K 
                of the Change (Details)                                          
90: R73         Medical Claims and Benefits Payable - Incurred      HTML     50K 
                Claims and Allocated Adjustment Expense (Details)                
91: R74         Medical Claims and Benefits Payable - Cumulative    HTML     41K 
                Paid Claims and Allocated Claims Adjustment                      
                Expenses (Details)                                               
92: R75         Medical Claims and Benefits Payable -               HTML     46K 
                Reconciliation of Claims Development (Details)                   
93: R76         Debt - Maturities (Details)                         HTML     73K 
94: R77         Debt - Schedule of Long-Term Debt (Details)         HTML     54K 
95: R78         Debt - Credit Agreement (Details)                   HTML     42K 
96: R79         Debt - Senior Notes (Details)                       HTML     51K 
97: R80         Income Taxes - Provision for Income Taxes           HTML     55K 
                (Details)                                                        
98: R81         Income Taxes - Reconciliation of the U.S. Federal   HTML     44K 
                Statutory Income Tax Rate (Details)                              
99: R82         Income Taxes - Deferred Tax Assets and Liabilities  HTML     65K 
                (Details)                                                        
100: R83         Income Taxes - Additional Information (Details)     HTML     50K  
101: R84         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     39K  
102: R85         Stockholders' Equity - Additional Information       HTML    111K  
                (Details)                                                        
103: R86         Stockholders' Equity - Components of Share-based    HTML     49K  
                Compensation (Details)                                           
104: R87         Stockholders' Equity - Restricted and Performance   HTML     64K  
                Stock Activity (Details)                                         
105: R88         Stockholders' Equity - Fair Value of Awards         HTML     47K  
                Granted and Vested (Details)                                     
106: R89         Stockholders' Equity - Stock Option Activity        HTML     50K  
                (Details)                                                        
107: R90         Employee Benefit Plans (Details)                    HTML     37K  
108: R91         Commitments and Contingencies (Details)             HTML     47K  
109: R92         Segments - Narrative (Details)                      HTML     33K  
110: R93         Segments - Schedule of Operating Segment            HTML     49K  
                Information (Details)                                            
111: R94         Segments - Reconciliation of Gross Margin to        HTML     66K  
                Consolidated Income (Details)                                    
112: R95         Condensed Financial Information of Registrant -     HTML    135K  
                Condensed Balance Sheets (Details)                               
113: R96         Condensed Financial Information of Registrant -     HTML     56K  
                Condensed Balance Sheets - Additional Information                
                (Details)                                                        
114: R97         Condensed Financial Information of Registrant -     HTML     98K  
                Condensed Statements of Operations (Details)                     
115: R98         Condensed Financial Information of Registrant -     HTML     64K  
                Condensed Statements of Comprehensive Income                     
                (Details)                                                        
116: R99         Condensed Financial Information of Registrant -     HTML     88K  
                Condensed Statements of Cash Flows (Details)                     
117: R100        Condensed Financial Information of Registrant -     HTML     45K  
                Notes to Condensed Financial Information (Details)               
119: XML         IDEA XML File -- Filing Summary                      XML    216K  
122: XML         XBRL Instance -- moh-20231231_htm                    XML   3.01M  
118: EXCEL       IDEA Workbook of Financial Report Info              XLSX    212K  
14: EX-101.CAL  XBRL Calculations -- moh-20231231_cal                XML    304K 
15: EX-101.DEF  XBRL Definitions -- moh-20231231_def                 XML    817K 
16: EX-101.LAB  XBRL Labels -- moh-20231231_lab                      XML   2.36M 
17: EX-101.PRE  XBRL Presentations -- moh-20231231_pre               XML   1.53M 
13: EX-101.SCH  XBRL Schema -- moh-20231231                          XSD    220K 
120: JSON        XBRL Instance as JSON Data -- MetaLinks              666±  1.01M  
121: ZIP         XBRL Zipped Folder -- 0001179929-24-000033-xbrl      Zip    893K  


‘EX-97’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 
  exhibit97_generalclawbac  
#606562v4 MOLINA HEALTHCARE, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Molina Healthcare, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined in the text of this Policy are defined in Section 11. Except as set forth in Section 8, this Policy replaces in its entirety the prior Clawback Policy of the Company effective March 10, 2013 (the “Prior Clawback Policy”). 1. Persons Subject to Policy This Policy shall apply to current and former Officers of the Company. Each Officer shall be required to sign an acknowledgment pursuant to which such Officer will agree to be bound by the terms of, and comply with, this Policy; however, any Officer’s failure to sign any such acknowledgment shall not negate the application of this Policy to the Officer. 2. Compensation Subject to the Policy This Policy shall apply to Incentive-Based Compensation received on or after the Effective Date. For purposes of this Policy, the date on which Incentive-Based Compensation is “received” shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is “received” in the Company’s fiscal period during which the relevant Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period. 3. Recovery of Compensation In the event that the Company is required to prepare a Restatement, the Company shall recover, reasonably promptly, the portion of any Incentive-Based Compensation that is Erroneously Awarded Compensation, unless the Committee has determined that recovery would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company. For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to any person’s right to voluntarily terminate employment for “good reason,” or due to a “constructive termination” (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates. 4. Manner of Recovery; Limitation on Duplicative Recovery The Committee shall, in its sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include, without limitation, reduction or cancellation by the Company or an affiliate of the Company of Erroneously Awarded Compensation, reimbursement or repayment by any person subject to this Policy of the Erroneously Awarded Compensation, and, to the extent permitted by law, an offset of the Erroneously Awarded Compensation against other compensation payable by the Company or an affiliate of the Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously


 
2 #606562v4 Awarded Compensation already recovered by the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation will be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person. 5. Administration This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all determinations necessary, appropriate or advisable for such purpose. The Board of Directors of the Company (the “Board”) may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the “Committee” shall be deemed to be references to the Board. Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company and its affiliates, equityholders and employees. The Committee may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules. 6. Interpretation This Policy will be interpreted and applied in a manner that is consistent with the requirements of the Applicable Rules, and to the extent they are inconsistent with such Applicable Rules, it shall be deemed amended to the extent necessary to ensure compliance therewith. 7. No Indemnification; No Personal Liability The Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant to this Policy , nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person’s potential obligations under this Policy. No member of the Committee or the Board shall have any personal liability to any person as a result of actions taken under this Policy and each member of the Committee and the Board shall be fully indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any actions taken under this Policy. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board under applicable law or Company policy. 8. Application; Enforceability Effective as of the Effective Date, the Policy shall supersede and replace in its entirety Prior Clawback Policy; provided, that, notwithstanding the foregoing, any cash incentive compensation or equity incentive awards that are received prior to the Effective Date shall continue to remain subject to the Prior Clawback Policy. Except as otherwise determined by the Committee or the Board, or to the extent specified above in respect of the Prior Clawback Policy, the adoption of this Policy does not limit, and is


 
3 #606562v4 intended to apply in addition to, any other clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or provisions of such effect contained in any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (the “Other Recovery Arrangements”). The remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or an affiliate of the Company. 9. Severability The provisions in this Policy are intended to be applied to the fullest extent of the law; provided, however, to the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. 10. Amendment and Termination The Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to time in its sole discretion. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association. 11. Definitions “Applicable Rules” means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company’s securities are listed, in each case, as may be amended from time to time, and any applicable rules, standards or other guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company’s securities are listed. “Committee” means the committee of the Board responsible for executive compensation decisions comprised solely of independent directors (as determined under the Applicable Rules), or in the absence of such a committee, a majority of the independent directors serving on the Board. “Erroneously Awarded Compensation” means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such current or former Officer based on a restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules. “Exchange Act” means the Securities Exchange Act of 1934, as amended. “Financial Reporting Measure” means any measure determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, including GAAP, IFRS and non- GAAP/IFRS financial measures, as well as stock or share price and total equityholder return.


 
4 #606562v4 “GAAP” means United States generally accepted accounting principles. “IFRS” means international financial reporting standards as adopted by the International Accounting Standards Board. “Impracticable” means (a) the direct costs paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation; provided that the Company has (i) made reasonable attempts to recover the Erroneously Awarded Compensation, (ii) documented such attempt(s), and (iii) provided such documentation to the relevant listing exchange or association, (b) to the extent permitted by the Applicable Rules, the recovery would violate the Company’s home country laws pursuant to an opinion of home country counsel; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such violation, and (ii) provided such opinion to the relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder. “Incentive-Based Compensation” means, with respect to a Restatement, any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person: (a) after beginning service as an Officer; (b) who served as an Officer at any time during the performance period for that compensation; (c) while the Company has a class of its securities listed on a national securities exchange or association; and (d) during the applicable Three-Year Period. “Officer” means each person who serves as an executive officer of the Company, as defined in Rule 10D-1(d) under the Exchange Act. “Restatement” means an accounting restatement to correct the Company’s material noncompliance with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements (a) that is material to the previously issued financial statements or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. “Three-Year Period” means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare such Restatement, or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement. The “Three-Year Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.


 
#606562v4 ACKNOWLEDGMENT AND CONSENT TO POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION The undersigned has received a copy of the Policy for Recovery of Erroneously Awarded Compensation (the “Policy”) adopted by Molina Healthcare, Inc. (the “Company”). In consideration of, and as a condition to, the receipt of future cash and equity incentive compensation from the Company, the undersigned agrees to the terms of the Policy and agrees that compensation received by the undersigned may be subject to reduction, cancellation, forfeiture and/or recoupment to the extent necessary to comply with the Policy, notwithstanding any other agreement to the contrary. The undersigned further acknowledges and agrees that the undersigned is not entitled to indemnification in connection with any enforcement of the Policy by the Company to the extent set forth therein and expressly waives any rights to such indemnification under the Company’s organizational documents or otherwise. ___________________ Date ________________________________________ Signature ________________________________________ Name ________________________________________ Title


 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/13/24SC 13G/A
For Period end:12/31/23
10/2/234,  8-K
3/10/13
 List all Filings 


17 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/27/23  Molina Healthcare, Inc.           10-Q        3/31/23   61:53M
10/27/22  Molina Healthcare, Inc.           10-Q        9/30/22   65:8.2M
 2/16/22  Molina Healthcare, Inc.           8-K:5,9     2/16/22   11:175K
 2/14/22  Molina Healthcare, Inc.           10-K       12/31/21  118:14M
11/16/21  Molina Healthcare, Inc.           8-K:1,2,8,911/16/21   12:27M
 9/09/21  Molina Healthcare, Inc.           8-K:1,5,7,9 9/08/21   12:365K                                   Business Wire/FA
 2/16/21  Molina Healthcare, Inc.           10-K       12/31/20  122:15M
11/17/20  Molina Healthcare, Inc.           8-K:1,2,8,911/17/20   12:961K                                   Business Wire/FA
 6/08/20  Molina Healthcare, Inc.           8-K:1,9     6/08/20   11:1.2M                                   Business Wire/FA
 6/02/20  Molina Healthcare, Inc.           8-K:1,2,8,9 6/02/20   12:922K                                   Business Wire/FA
10/30/19  Molina Healthcare, Inc.           10-Q        9/30/19   82:10M
 7/31/19  Molina Healthcare, Inc.           10-Q        6/30/19   85:18M
 2/19/19  Molina Healthcare, Inc.           10-K       12/31/18  137:39M
 6/14/13  Molina Healthcare, Inc.           8-K:1,5,9   6/14/13    4:171K                                   Donnelley … Solutions/FA
 2/28/13  Molina Healthcare, Inc.           10-K       12/31/12  127:25M                                    Workiva Inc.
 3/14/07  Molina Healthcare, Inc.           10-K       12/31/06   14:9.3M                                   Donnelley … Solutions/FA
12/30/02  Molina Healthcare, Inc.           S-1                   21:4.9M                                   Donnelley Fin’l S… 05/FA
Top
Filing Submission 0001179929-24-000033   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 3:35:39.2pm ET